Poor sleep may up progression of chronic kidney disease

Image
ANI Washington D.C. [U.S.A.]
Last Updated : Sep 17 2017 | 11:57 AM IST

Beware! People with chronic kidney disease may be vulnerable to the deleterious effects of poor sleep, almost 6.5 hours per night, according to a new study.

Chronic kidney disease is characterised by gradual loss of kidney function over time and may eventually lead to kidney failure, leading patients to undergo dialysis or a kidney transplant.

Chronic kidney disease can be caused by diabetes, high blood pressure and other disorders.

Previous studies have suggested that poor sleep is common among patients with chronic kidney disease, but few studies have looked at the effects of sleep on the progression of the disease.

Lead researcher Dr. Ana Ricardo from the University of Illinois at Chicago's college of medicine and Kristen Knutson, associate professor of neurology and preventive medicine at Northwestern University, examined the association between sleep duration and quality on progression of chronic kidney disease among 431 patients with chronic kidney disease.

The participants had a mean age of 60-years-old, in which 48 per cent were women and half had diabetes.

The participants were asked to wear an accelerometer on their wrists for five to seven days to measure motion and provide information on duration of sleep as well as periods of wakefulness.

Ricardo noted that sleep is seriously impaired in the patients with chronic kidney disease.

The findings indicated that the average hours of sleep among the participants were 6.5 hours per night.

Interrupted sleep, also known as sleep fragmentation, was associated with a slightly elevated risk of developing kidney failure.

Over the five-year follow-up, the results suggested that 70 participants developed kidney failure and 48 participants died.

Ricardo noted that each hour less of sleep duration increases the risk for deterioration of kidney function over time.

The patients with chronic kidney disease often have co-occurring hypertension, obesity and diabetes.

The research appeared in the journal of the American Society of Nephrology.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 17 2017 | 11:57 AM IST

Next Story